| Dr Jonathan Bass, MD | |
|
2500 Metrohealth Dr, Cleveland, OH 44109-1900 | |
| (216) 778-7800 | |
| Not Available |
| Full Name | Dr Jonathan Bass |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 45 Years |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659350247 | NPI | - | NPPES |
| 0575944 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | 35045606 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Metrohealth System | 8628982949 | 1026 |
News Archive
Currently more than 10% of preschoolers in the U.S. are obese and effective strategies that target pregnancy, infancy, and toddlers are urgently needed to stop the progression of the childhood obesity epidemic, as proposed in an article in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Increasing the levels of a signaling molecule found in the brain can positively alter response to stress, revealing a potential new therapeutic target for treatment of depression, UT Southwestern Medical Center researchers said.
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.
› Verified 2 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
Currently more than 10% of preschoolers in the U.S. are obese and effective strategies that target pregnancy, infancy, and toddlers are urgently needed to stop the progression of the childhood obesity epidemic, as proposed in an article in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Increasing the levels of a signaling molecule found in the brain can positively alter response to stress, revealing a potential new therapeutic target for treatment of depression, UT Southwestern Medical Center researchers said.
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Bass, MD 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 464-7770 | Dr Jonathan Bass, MD 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 |
News Archive
Currently more than 10% of preschoolers in the U.S. are obese and effective strategies that target pregnancy, infancy, and toddlers are urgently needed to stop the progression of the childhood obesity epidemic, as proposed in an article in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Increasing the levels of a signaling molecule found in the brain can positively alter response to stress, revealing a potential new therapeutic target for treatment of depression, UT Southwestern Medical Center researchers said.
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.
› Verified 2 days ago
Carol C Slover, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Wilma F Bergfeld, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Antoine Amado De Olazaval, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk A61, Cleveland, OH 44195 Phone: 216-445-3643 Fax: 216-636-5151 | |
Katherine Camille Disano, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-5394 | |
Dr. John Scott Anthony, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, St40, Cleveland, OH 44195 Phone: 440-878-2500 | |
Dr. Christine Jaworsky, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Christine M Poblete-lopez, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk A61, Cleveland, OH 44195 Phone: 216-444-3345 |